To test whether SR-BI is necessary for the pigmentation phenotype in melanoma we used the melanoma cell line VM21, derived from early growth phase melanoma, and WM3060, derived from metastatic melanoma, to investigate the effect of SR-BI siRNA treatment. Here, SCARB1 is linked to metastatic melanoma.